Federal Register · Regulatory notice
Determination That Protamine Sulfate (Protamine Sulfate) Intravenous; Solution, 50 Milligrams/5 Milliliters, and Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness
The Food and Drug Administration (FDA or Agency) has determined that the drug products listed in this document were not withdrawn from sale for reasons of safety or effectiveness. This determination means that FDA will not begin procedures to withdraw approval of abbreviated new drug applications (ANDAs) that refer to these drug products, and it will allow FDA to continue to approve ANDAs that refer to the products as long as they meet relevant legal and regulatory requirements.
Follow ABBV- Became public
- Jun 8, 2026
- Event / period date
- Not stated
- Collected
- Nov 8, 2026, 7:46 PM EST
Why this is connected
The source explicitly mentions AbbVie Inc.. A mention alone does not establish a financial benefit.
Source evidence
Read the source excerpt or record
cosal. EQ 0.6 mg Base; eq 0.8 mg Base; EQ 1.2 mg Base; EQ 1.6 mg Base. NDA 020757.......... AVAPRO........... Irbesartan....... 75 mg........... Tablet; Oral.... Sanofi-Aventis U.S. LLC. NDA 021065.......... FEMHRT........... Ethinyl 0.0025 mg; 0.5 Tablet; Oral.... Allergan Estradiol; mg. Pharmaceuticals Norethindrone International Acetate. Ltd. NDA 021087.......... TAMIFLU.......... Oseltamivir EQ 30 mg Base; Capsule; Oral... Roche. Phosphate. EQ 45 mg Base. [[Page 34635]] NDA 021227.......... CANCIDAS......... Caspofungin 50 mg/Vial; 70 Powder; Merck Sharp & Acetate. mg/Vial. Intravenous. Dohme. NDA 021506.......... MYCAMINE......... Micafungin Sodium EQ 50 mg Base/ Injectable; Astellas Pharma Vial; EQ 100 mg Intravenous. US Inc. Base/Vial. NDA 021520.......... SYMBYAX.......... Fluoxetine EQ 25 mg Base; Capsule; Oral... Eli Lilly and Hydrochloride; EQ 3 mg Base; Co. Olanzapine. EQ 25 mg Base; EQ 6 mg Base; EQ 25 mg Base; EQ 12 mg Base; EQ 50 mg Base; EQ 6 mg Base; EQ 50 mg Base; EQ 12 mg Base. NDA 021947.......... FENTORA.......... Fentanyl Citrate. EQ 0.1 mg Base; Tablet; Buccal, Cephalon, LLC. EQ 0.2 mg Base; Sublingual. EQ 0.4 mg Base; EQ 0.6 mg Base; EQ 0.8 mg Base. NDA 022076.......... LOCOID........... Hydrocortisone 0.1%............ Lotion; Topical. Bausch Health. Butyrate. NDA 022116.......... LEXIVA........... Fosamprenavir EQ 50 mg Base/mL Suspension; Oral ViiV Hea
Congressional trading in ABBV
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Oct 7, 2026$15K–$50K
Rep. Ro Khanna (D-CA-17)
$15K–$50K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Sep 18, 2026$15K–$50K
Rep. Pete Sessions (R-TX-17)
$15K–$50K · Traded Sep 14, 2026 · disclosed Sep 18, 2026
- Jul 21, 2026$15K–$50K
Sen. Alan Armstrong (R-OK)
$15K–$50K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Jun 3, 2026$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
$1K–$15K · Traded May 5, 2026 · disclosed Jun 3, 2026 · Joint
- Feb 6, 2026$15K–$50K
Rep. Ro Khanna (D-CA-17)
$15K–$50K · Traded Jan 29, 2026 · disclosed Feb 6, 2026 · Spouse
- Jan 15, 2026$1K–$15K
Rep. Julie Johnson (D-TX-32)
$1K–$15K · Traded Dec 18, 2025 · disclosed Jan 15, 2026 · Joint
- Jan 13, 2026$1K–$15K
- Jan 13, 2026$1K–$15K
Rep. Julia Letlow (R-LA-5)
$1K–$15K · Traded Apr 28, 2025 · disclosed Jan 13, 2026 · filed 260 days later
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.